The Biden-era Inflation Reduction Act directed Medicare to identify expensive prescription drugs that could be made cheaper.

Source: Faith Leonard and Gretchen Jacobson, “What Does the Decline in Medicare Part D Plan Availability Mean for Beneficiaries?,” To the Point (blog), Commonwealth Fund, Dec. 17, 2025.

Headshot courtesy The Fussell Group. Lower Out of Pocket Drug Costs starting in 2025? Yes! Medicare beneficiaries’ out-of-pocket costs for Part D prescription drugs will be capped at $2,000 annually.

The Centers for Medicare & Medicaid Services Dec. 23 introduced a new drug pricing model, BALANCE, for Medicare Part D and ...

Big changes have come to Medicare’s prescription drug coverage, known as Part D, in 2026 that could affect how you pay for ...

Discover how Medicare provides healthcare to those 65 and older. Learn about eligibility, coverage options, and how to enroll ...

Medicare Part D spending on diabetes drugs increased 364% from 2019 to 2023, driven by GLP-1 and SGLT-2 inhibitors. Metformin spending decreased by 5%, contrasting with the surge in other diabetes ...

Savings will help people struggling with high drug prices and improve access to life-saving medications for Medicare Part D ...

New abilities for Medicare to negotiate prescription prices mean certain drugs should be 50% to 70% cheaper for many ...

Knowing how Medicare is evolving and which benefits you can rely on will help you focus on whether Original Medicare or a particular Medicare Advantage plan will serve you best. Medical costs are ...

Pennsylvanians will see their out-of-pocket costs for 10 medications drop by 53% on average, according to a new AARP report.